MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lipid metabolism"

  • 2026 International Congress

    Circadian Regulator REV-ERBα Drives Microglial Lipid Metabolic Reprogramming and Cognitive Impairment in Parkinson‘s Disease

    T. Deng (Guang Zhou, China)

    Objective: To investigate the mechanisms by which sleep disturbance exacerbates motor and cognitive deficits in Parkinson’s disease (PD), and to determine how alterations in the…
  • 2026 International Congress

    Prosaposin differentially modulates lipid metabolism of striatal and non-striatal dopamine D1 receptor-expressing neurons and regulates L-DOPA-induced dyskinesia

    Y. He, I. Kaya, Y. Yang, A. Nilsson, R. Shariatgorji, I. Mantas, X. Zhang, P. Andren, P. Svenningsson (Solna, Sweden)

    Objective: Chronic treatment of L-DOPA causes dyskinesia (LID) in PD patients. We aim to understand LID from a lipid-metabolism perspective and identify novel therapeutic targets.…
  • 2026 International Congress

    Disrupted Lipid Homeostasis and Mitochondrial Remodeling in A53T α-Synuclein Astrocytes

    I. Goglia, SL. Pereira, M. Tziortziou, P. Mulica, S. Delcambre, L. Gallucci, L. Neises, M. Mendes, G. Dittmar, J. Meiser, A. Monzel, E. Glaab, A. Grünewald (Belvaux, Luxembourg)

    Objective: This study explores lipid metabolic alterations in human astrocytes carrying the A53T α-synuclein mutation and examines their link to mitochondrial organization and cellular bioenergetics.…
  • 2026 International Congress

    Contribution of blood lipid profile to long-term outcome in idiopathic normal pressure hydrocephalus

    J. Bissacco, D. Mascioli, C. Simonetta, M. Mancini, V. Buttarazzi, M. Conti, F. Veltri, S. Bagetta, M. Pierantozzi, A. Stefani, F. Buttari, D. Centonze, A. Pesce, M. Pieri, S. Borrelli, F. Di Giuliano, T. Schirinzi (Rome, Italy)

    Objective: Here, we outlined the blood lipid profile, including derived indices of metabolic dyshomeostasis, in iNPH patients, and investigated relationships with brain MRI-based pathology markers,…
  • 2026 International Congress

    Metabolomic profile as a biomarker of non-motor symptoms severity in patients with Parkinson’s disease

    K. Aguiar, A. Carioca, I. Santos, F. Rolim, A. Ferreira Gomes, AS. Lima Verde, C. Figueiredo, F. Carvalho (Fortaleza, Brazil)

    Objective: To investigate possible associations between serum metabolomic profiles and non-motor symptoms (NMS) frequency and intensity in PD patients Background: Metabolomic studies are providing growing…
  • 2025 International Congress

    Genetic Correlations Between Parkinson’s Disease and Circulating Metabolites

    M. Tan, T. Ascencio, S. Rodriguez-Quiroga, J. Largo González, S. Peña Martinez, L. Hernandez Delgado, A. Noyce (San Salvador, El Salvador)

    Objective: To use genome-wide association studies (GWASs) to identify genetic correlations between Parkinson’s disease (PD) and circulating metabolites. Background: Metabolomics is the study of small…
  • 2025 International Congress

    Rare Variant Analysis of Sphingolipid-related Genes in Large Chinese Parkinson’ s Disease Cohorts

    JB. Liu, YW. Zhao, XM. Guo, Q. Yin, R. Gao, BS. Tang, JF. Guo (Changsha, China)

    Objective: This study investigated the link between rare variants in sphingolipid-related genes and Parkinson’s disease (PD) in a Chinese mainland population. Background: Recently, growing evidence…
  • 2025 International Congress

    Association of high-density lipoprotein cholesterol and related inflammatory index with neurodegeneration in drug-naïve dementia with Lewy bodies

    T. Umehara, M. Mimori, M. Ozawa, T. Shiraishi, T. Kitagawa, M. Ikeda, H. Matsuno, S. Omoto, R. Sengoku, H. Murakami, Y. Iguchi (Tokyo, Japan)

    Objective: We aimed to clarify the association of serum cholesterol levels and related inflammatory index with the degeneration of nigrostriatal dopaminergic neurons and clinical symptoms…
  • 2025 International Congress

    Oligodendrocyte-specific mRNA therapy with lipid nanoparticles

    M. Sawamura, K. Tachikawa, R. Hikawa, H. Yamakado, R. Takahashi, S. Matsuzawa (San Diego, USA)

    Objective: To develop lipid nanoparticles with high efficiency and specificity to introduce mRNA into oligodendrocytes. To denmonstrate the potential therapy of Krabbe disease as one…
  • 2025 International Congress

    Using Zebrafish Model to Investigate Complex Hereditary Spastic Paraplegia Caused by EPT1 Variants

    S. Wang, S. Banka, M. Lowe, A. Nicolaou (Manchester, United Kingdom)

    Objective: To generate disease-representative zebrafish models using CRISPR-Cas9 technique.To characterise the zebrafish models by performing phenotypic characterization, neurobiological experiments, lipidomic and RNASeq studies.To test targeted…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 10
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley